Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Behav Neurol. 2009;21(1):3-12. doi: 10.3233/BEN-2009-0230.

Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Author information

  • 1Deptartment of Psychiatry, University of California San Diego, San Diego, CA, USA. Fennema@UCSD.edu

Abstract

Current research supports the strong potential of structural MRI profiles, even within cross-sectional designs, as a promising method for the discrimination of Alzheimer's Disease (AD) from normal controls and for the prediction of Mild Cognitive Impairment (MCI) progression and conversion to AD. Findings suggest that measures of structural change in mesial and lateral temporal, cingulate, parietal and midfrontal areas may facilitate the assessment of a treatment's ability to halt the progressive structural loss that accompanies clinical decline in MCI. The performance of prediction is likely to continue to improve with the incorporation of measures from other neuroimaging modalities, clinical assessments, and neuromedical biomarkers, as the regional profile of individuals at risk for progression is refined.

PMID:
19847040
[PubMed - indexed for MEDLINE]
PMCID:
PMC2873895
Free PMC Article

Images from this publication.See all images (3)Free text

Fig. 1
Fig. 2
Fig. 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IOS Press Icon for PubMed Central
    Write to the Help Desk